Post Resch Tallon Group Inc. Novartis Ag Transaction History
Post Resch Tallon Group Inc.
- $104 Billion
- Q2 2025
A detailed history of Post Resch Tallon Group Inc. transactions in Novartis Ag stock. As of the latest transaction made, Post Resch Tallon Group Inc. holds 1,665 shares of NVS stock, worth $195,970. This represents 0.19% of its overall portfolio holdings.
Number of Shares
1,665Holding current value
$195,970% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,542Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.39 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.22 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.01 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$830 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$796 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $253B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...